İrkeç, C. And Altan, N. 2017. Serum fractalkine levels in patients with vascular dementia,Alzheimer's disease and mild cognitive impairment. 23th Congress of WCN , (Kyoto, Japan), 663.

İrkeç, C., & Altan, N., (2017). Serum fractalkine levels in patients with vascular dementia,Alzheimer's disease and mild cognitive impairment . 23th Congress of WCN (pp.663). Kyoto, Japan

İrkeç, CEYLA, And Nilgün Altan. "Serum fractalkine levels in patients with vascular dementia,Alzheimer's disease and mild cognitive impairment," 23th Congress of WCN, Kyoto, Japan, 2017

İrkeç, CEYLA And Altan, Nilgün. "Serum fractalkine levels in patients with vascular dementia,Alzheimer's disease and mild cognitive impairment." 23th Congress of WCN , Kyoto, Japan, pp.663, 2017

İrkeç, C. And Altan, N. (2017) . "Serum fractalkine levels in patients with vascular dementia,Alzheimer's disease and mild cognitive impairment." 23th Congress of WCN , Kyoto, Japan, p.663.

@conferencepaper{conferencepaper, author={CEYLA İRKEÇ And author={Nilgün Altan}, title={Serum fractalkine levels in patients with vascular dementia,Alzheimer's disease and mild cognitive impairment}, congress name={23th Congress of WCN}, city={Kyoto}, country={Japan}, year={2017}, pages={663} }